Grade “A” for Hawaiʻi Medicaid

Great news! In February 2023, the national report card on Hep C treatment access via Medicaid for Hawaiʻi was upgraded from a “D” in 2022 to an “A” in 2023. This grade change was in direct response to the recent MedQUEST memo which reduced barriers to Hep C medication.

Thanks to MedQUEST and all of you for helping Hawaiʻi move towards hepatitis elimination! Read the press release here.

Previous
Previous

New! Hep B Screening for All Adults

Next
Next

Hep B Mortality in HI Data